Folfirinox + Cetuximab Chemotherapy, in First Line, With Wild RAS and According to BRAF Status in Metastatic Colorectal Cancer

NCT03914170 · clinicaltrials.gov ↗

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Folfirinox + cetuximab

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle

Collaborators

[object Object]